Bottom line
How much do FBTAX and RYOIX overlap?
47% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 42.6% of FBTAX's assets and 36.5% of RYOIX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings FBTAX and RYOIX have in common
| Holding | % of FBTAX | % of RYOIX | Overlap |
|---|---|---|---|
| Abbvie Inc | 14.71% | 8.17% | 8.17% |
| Gilead Sciences Inc | 5.70% | 4.49% | 4.49% |
| Alnylam Pharmaceuticals Inc | 3.62% | 2.36% | 2.36% |
| Insmed Inc | 3.05% | 1.79% | 1.79% |
| Revolution Medicines Inc | 3.00% | 2.48% | 2.48% |
| Argenx Se | 3.00% | 1.48% | 1.48% |
| Biogen Inc | 2.71% | 2.13% | 2.13% |
| Amgen Inc | 2.37% | 5.05% | 2.37% |
| Moderna Inc | 1.60% | 2.15% | 1.60% |
| Natera Inc | 1.43% | 2.12% | 1.43% |
| Vertex Pharmaceuticals Inc | 1.39% | 4.32% | 1.39% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FBTAX
- Spyre Therapeutics Inc — 3.83%
- Dianthus Therapeutics Inc — 3.55%
- Cogent Biosciences Inc — 3.25%
- Oruka Therapeutics Inc — 3.24%
- Ascendis Pharma A/s — 2.99%
- Mbx Biosciences Inc — 2.45%
- Amylyx Pharmaceuticals Inc — 2.25%
- Vaxcyte Inc — 1.97%
- Fidelity Revere Street Trust — 1.96%
- Relay Therapeutics Inc — 1.58%
- Viridian Therapeutics Inc — 1.53%
- Kiniksa Pharmaceuticals International Plc — 1.41%
- Enliven Therapeutics Inc — 1.25%
- Alumis Inc — 1.22%
Only in RYOIX
- Regeneron Pharmaceuticals Inc — 2.93%
- Beone Medicines Ltd — 2.17%
- Royalty Pharma Plc — 2.01%
- Illumina Inc — 1.94%
- United Therapeutics Corp — 1.72%
- Guardant Health Inc — 1.72%
- Roivant Sciences Ltd — 1.66%
- Incyte Corp — 1.62%
- Viatris Inc — 1.55%
- Neurocrine Biosciences Inc — 1.52%
- Jazz Pharmaceuticals Plc — 1.42%
- Bridgebio Pharma Inc — 1.38%
- Ionis Pharmaceuticals Inc — 1.35%
- Cytokinetics Inc — 1.35%
Asset mix
| Asset type | FBTAX | RYOIX |
|---|---|---|
| Stocks | 98.2% | 99.6% |
| Cash & short-term funds | 2.4% | 0.6% |
| Preferred stock | 1.5% | — |
| Repurchase agreements | — | 0.6% |
| Bonds | 0.1% | — |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Country mix
| Country | FBTAX | RYOIX |
|---|---|---|
| US | 87.8% | 85.8% |
| NL | 4.3% | 1.5% |
| CH | — | 3.3% |
| GB | 1.8% | 3.2% |
| DK | 3.0% | 0.9% |
| IE | — | 2.7% |
| KY | 1.8% | 0.5% |
| BM | 1.2% | 1.7% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do FBTAX and RYOIX overlap?
What stocks do FBTAX and RYOIX have in common?
Should I own both FBTAX and RYOIX?
Which holds more stocks, FBTAX or RYOIX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.